| Xcovery is creating next generation targeted small molecule inflammation and oncology therapies. Lead programs - currently in preclinical development - combine world-class medicinal chemistry and biology from academic partners to produce novel, less toxic and more efficacious kinase therapeutics with better drug properties than existing therapies. |
|
| Xcovery is driven by |
|
| . |
The entrepreneurial leadership of Mr. Sheridan Snyder - founder and former CEO of Genzyme, Upstate Biotechnology and Biotage.
|
|
| . |
The scientific leadership of Dr. Chris Liang, co-inventor of Sutent® and currently Director of Medicinal Chemistry at Scripps Research Institute. |
|
|
| Xcovery's pipeline consists of three rapidly moving pre-clinical therapeutic programs: two oncology programs and one pre-clinical inflammation program, each with lead candidate designs a generation ahead of current approaches and products. |
|
| Xcovery is based in West Palm Beach, Florida, and is the first spin-out from the new Scripps Research Institute located in Jupiter, Florida. |
| |